Le Lézard
Classified in: Health, Science and technology

Distribution Deal Trends in Diagnostics Report 2024 with Analysis of Deals Signed Since 2016 - ResearchAndMarkets.com


The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.

Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals.

Fully revised and updated, the report provides details of distribution deals from 2016 to 2024. The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of distribution deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in distribution as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of distribution deals.

Chapter 4 provides a review of the leading distribution deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active distribution dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

The deal directory includes a comprehensive listing of all distribution deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in distribution dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about distribution alliances.

Distribution Deals in Diagnostics provides the reader with the following key benefits:

Distribution Deals in Diagnostics includes:

In Distribution Deals in Diagnostics, the available deals are listed by:

Analyzing contract agreements allows due diligence of:

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

2.1. Introduction

2.2. Definition of distribution deal

2.3. Trends in distribution deals since 2016

2.3.1. Distribution dealmaking by year, 2016-2024

2.3.2. Distribution dealmaking by phase of development, 2016-2024

2.3.3. Distribution dealmaking by therapy area, 2016-2024

2.3.4. Distribution dealmaking by technology type, 2016-2024

2.3.5. Distribution dealmaking by most active company, 2016-2024

2.4. Reasons for entering into distribution partnering deals

Chapter 3 - Overview of distribution deal structure

3.1. Introduction

3.2. Distribution agreement structure

Chapter 4 - Leading distribution deals

4.1. Introduction

4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

5.1. Introduction

5.2. Top 25 most active distribution dealmakers

Deal directory

Deal directory - distribution dealmaking by companies A-Z

Deal directory - distribution dealmaking by therapy area

Deal directory - distribution dealmaking by technology type

For more information about this report visit https://www.researchandmarkets.com/r/gm3n02

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: